A yw Llywodraeth Cymru wedi cael trafodaethau gyda Vertex Pharmaceuticals ynghylch y cyffur Orkambi ac, os felly, ar sawl achlysur y mae'r ddau ohonynt wedi trafod argaeledd y cyffur yng Nghymru?
Wedi'i ateb gan Ysgrifennydd y Cabinet dros Iechyd a Gwasanaethau Cymdeithasol | Wedi'i ateb ar 19/07/2018
Neither I nor my officials have had any formal discussions with Vertex Pharmaceuticals regarding access to Orkambi®. The position regarding access to lumacaftor/ivacaftor (Orkambi®) remains unchanged since my answers to Welsh Assembly Questions 73727 and 73835 on 4 July and 74061 on 15 August last year and Welsh Assembly Question 75748 in February this year.